- Moderna, Inc.’s (MRNA) current price is 887% above the all-time low.
- MRNA stock has a P/E ratio of 40.8
- Moderna, Inc.’s (NASDAQ: MRNA)’s live market cap is $44.2 Billion.
Moderna, Inc. (MRNA) is a pharmaceutical company. MRNA is basically known for developing mRNA-based vaccines. The company came to be known after its work in developing COVID-19 vaccines.
Financial Data of Moderna Inc. (NASDAQ: MRNA)
The current market price of Moderna Inc. (MRNA) stock is $116.24. The market cap of MRNA is $44.24 Billion. The stock has a beta of 0.50 and an EPS of $2.72 per share.
The 52-week high of the Moderna Inc. stock is $217.25 and the 52-week low is $95.02. The average volume of the MRNA stock is $4.7 Million.
The revenue of Moderna Inc. stock has been increasing for the last 3 quarters. The current revenue has decreased from $5.08 Billion to $344 Million, with an average decrease of 72.55% per quarter.
The price of the Moderna Inc. (MRNA) stock declined by 17.6% in the last 3 months which represents how the stock is currently in a downtrend.
As per the data published on TradingView, it can be observed that the quarterly profit margin of the MRNA stock is declining by a huge percentage along with the net income.
The MRNA stock has a P/E ratio of 40.8. This indicates that the stock price of MRNA is slightly on the higher side. This might attract less interest from the buyers.
Moderna Inc. (MRNA) Technical Analysis
Moderna, Inc. (MRNA) stock price is currently in a downtrend. The price is forming a lower-low pattern. The overall structure of the MRNA stock is forming a weak structure and the price is likely to decline in the upcoming days.
Moderna Inc.’s stock price is weak. The MRNA price is trading below the 50-day and 100-day EMA levels. This is a bearish sign and shows that the price will fall.
The MACD line for the MRNA stock is trading below the signal line. Also, there is a red histogram formation in the MRNA stock. This suggests that the stock is currently bearish and prices may fall in the next few days.
As per the analysis, the price of Moderna, Inc. stock (MRNA) has given a breakdown from the major support level. The price has shown a YTD fall of 35%. The EMA and MACD of the MRNA stock are also bearish.
Therefore, it indicates that the price is currently forming a weak structure and it is likely to see new lows in the upcoming days.
- Support Level: $92
- Resistance Level: $116
The views and opinions of the author, or anyone named in this article, are for informational purposes only. They do not offer financial, investment, or other advice. Investing or trading crypto assets involves the risk of financial loss.